<DOC>
	<DOC>NCT00247429</DOC>
	<brief_summary>In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.</brief_summary>
	<brief_title>Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients older than 60 years Depressive syndrome with associated anxiety symptoms, according to a symptoms intensity HAMD17Â³14 Participation in other studies in the last 3 months before the start of the study Known hypersensibility to venlafaxine Clinically significant abnormalities according to the venlafaxine labeling</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>depression</keyword>
	<keyword>anxiety</keyword>
	<keyword>elderly</keyword>
</DOC>